Amgen Earnings Down on Restructing Costs

LOS ANGELES — Biotech company Amgen Inc. on Wednesday reported flat revenue and lower profit in the third quarter as the company continues to deal with a blow to its business dealt by federal regulators.

The Thousand Oaks company reported net income of $201 million, or 18 cents per share, for the quarter ended Sept. 30, down 82 percent from $1.1 billion, or 94 cents per share, in the same period last year.

This year's profits were hit by write-offs of nearly $1 billion stemming from an acquisition and restructuring costs.

Revenue in the quarter was unchanged at $3.61 billion.

Excluding one-time charges and stock options expenses, the company said it would have reported earnings of $1.08 per share, a slight increase over the $1.04 per share in the same period last year.

On that basis, analysts surveyed by Thomson Financial had expected per share earnings of $1.03.

Back To Top

	Aetna 3Q Up, As Is Outlook	Associated Press	Thu Oct 25	0
	US Airways Swings to 3Q Profit	Associated Press	Wed Oct 24	0
	General Dynamics 3Q Earns Up 24 Percent	Associated Press	Tue Oct 23	0
	Corning 3Q Profit Climbs 41 Percent	Associated Press	Wed Oct 24	0
	Raytheon 3Q Profit Slides on Charges	Associated Press	Wed Oct 24	0